IL22 and multiple sclerosis: This may stimulate a defensive pathway When released from Th17 ​cells in the periphery, Il-22 may drive immunopathogenesis in multiple sclerosis, and may mediate anti-inflammatory activity in astrocytes through a similar pathway.